½ÃÀ庸°í¼­
»óǰÄÚµå
1316288

¼¼°èÀÇ ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå(2023-2030³â)

Global Medical Device 3D Printing Market - 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: DataM Intelligence | ÆäÀÌÁö Á¤º¸: ¿µ¹® 195 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

½ÃÀå °³¿ä

¼¼°è ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀåÀº 2022³â 26¾ï ´Þ·¯, 2030³â¿¡´Â 79¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¼öÀͼº ÀÖ´Â ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¼¼°è ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀåÀº ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È 15.7%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

3D ÇÁ¸°ÆÃÀº ÀÇÁ·°ú º¸Á¶±â Á¦Á¶¿¡ Å« º¯È­¸¦ °¡Á®¿Ô½À´Ï´Ù. ÀÌ ±â¼úÀ» ÅëÇØ °¡º±°í Á¤È®ÇÏ°Ô ¸ÂÀ¸¸ç »ç¿ëÀÚ¿¡°Ô ´õ Æí¾ÈÇϰí À¯¿ëÇÑ º¸Á¶±â±¸¸¦ Á¦ÀÛÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù.

¿Ü°úÀÇ»çµéÀº 3D ÇÁ¸°ÆÃÀ» ÅëÇØ ȯÀÚº°·Î °íÀ¯ÇÑ ¼ö¼ú Áöħ°ú µµ±¸¸¦ ¸¸µé ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¸Å´º¾óÀº ¼ö¼ú °á°ú¸¦ °³¼±Çϰí, ¼ö¼ú À§ÇèÀ» ÁÙÀ̸ç, Á¤È®ÇÑ ¼ö¼ú Àü Áغñ¸¦ µ½½À´Ï´Ù. ¶ÇÇÑ Æ¯Á¤ ¼ö¼úÀÇ Çʿ並 ÃæÁ·½Ã۱â À§ÇØ Æ¯º°ÇÑ µµ±¸¸¦ ¸¸µé ¼öµµ ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¿¹Ãø ±â°£ µ¿¾È ¼¼°è ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÒ ÁÖ¿ä ¾÷üµéÀÇ È°¾àÀÌ µ¸º¸ÀÓ

2023³â 6¿ù, ÀÇ·á±â±â Á¦Á¶ ºÐ¾ß¿¡¼­ »ç¾÷À» Àü°³Çϰí ÀÖ´Â EOS, Precision ADM, Orthopaedic Innovation Centre(OIC), Tecomet µî 4°³ ±â¾÷ÀÌ Çù·Â °ü°è¸¦ ¸Î¾ú½À´Ï´Ù. À̹ø Á¦ÈÞ¸¦ ÅëÇØ ÀÇ·á±â±â¿ë ÀûÃþÁ¦Á¶(AM)¸¦ À§ÇÑ Á¾ÇÕÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÒ ¿¹Á¤ÀÔ´Ï´Ù.

ÀÇ·á±â±â¿ë AM Á¦Á¶¸¦ È®´ëÇϱâ À§Çؼ­´Â ÇÁ¸°ÆÃ»Ó¸¸ ¾Æ´Ï¶ó ¼³°è, ÈÄó¸®, °Ë»ç, ¸ê±Õ, Æ÷Àå µî Àüü ÇÁ·Î¼¼½º üÀÎÀ» Àß ÀÌÇØÇØ¾ß ÇÕ´Ï´Ù. ÀÇ·á±â±â Á¦Á¶¾÷ü°¡ ±ÔÁ¦ ȯ°æÀÇ ¾î·Á¿òÀ» ±Øº¹ÇÏ°í °íǰÁúÀÇ ½Å·ÚÇÒ ¼ö ÀÖ´Â Á¦Ç°À» °ø±ÞÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀ¸·Î ¼¼°è ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå¿¡ ¼ºÀå ±âȸ Á¦°ø

3D Printing in Medicine¿¡ °ÔÀçµÈ ±â»ç¿¡ µû¸£¸é, 2022³â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº ÀÌ¹Ì Á¸ÀçÇÏ´Â ÀÇ·á±â±â ±ÔÁ¤À» ÅëÇØ 3DÇÁ¸°ÆÃ ±â±â¸¦ °ü¸®ÇÒ ¿¹Á¤ÀÔ´Ï´Ù. ±×·¯³ª 3D ÇÁ¸°ÆÃÀÌ ÀÇ·á »ê¾÷ Àü¹ÝÀ¸·Î ºü¸£°Ô È®»êµÊ¿¡ µû¶ó FDA´Â Ä¡·á ½ÃÁ¡(PoC) 3D ÇÁ¸°ÆÃ¿¡ ƯȭµÈ Ç¥Áذú ±ÔÁ¤À» ¸¶·ÃÇÏ´Â µ¥ Á¡Á¡ ´õ ¸¹Àº °ü½ÉÀ» ±â¿ïÀ̰í ÀÖ½À´Ï´Ù.

ÃÖ±Ù 3D ÇÁ¸°ÆÃ ÀÇ·á±â±â ¿¬±¸ÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ÀÇ·á ÇöÀå(PoC) ÀÇ·á±â±â Á¦Á¶°¡ ºü¸£°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, PoC 3D ÇÁ¸°ÆÃÀº ȯÀÚ °á°ú¸¦ °³¼±ÇÏ°í ¼ö¼ú½ÇÀÇ ½Ã°£°ú ºñ¿ëÀ» Àý°¨ÇÒ ¼ö ÀÖ´Â ÀáÀç·ÂÀ» °¡Áö°í ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, ÀÌ·¯ÇÑ ¼³°è ¹× Á¦Á¶ ȯ°æÀº ÀÇ·á±â±â Á¦Á¶¾÷ü¿Í Ä¡·á Á¦°øÀÚÀÇ ±¸ºÐÀ» ¸ðÈ£ÇÏ°Ô ¸¸µé°í ±ÔÁ¦ ºÒÈ®½Ç¼ºÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

COVID-19 ¿µÇ⠺м®

COVID-19 »çÅ´ ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå¿¡ Å« ¿µÇâÀ» ¹ÌÃÆÀ¸¸ç, COVID-19 °Ë»ç ±ÔÁ¦·Î ÀÎÇØ °Ë»ç ŰƮ¿Í Áø´Ü µµ±¸¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇß½À´Ï´Ù. °Ë»ç ŰƮ¿Í Áø´Ü µµ±¸ÀÇ ÀϺÎÀÎ ºñÀεΠ¸éºÀ°ú °Ëü äÃë ¿ë±â´Â 3D ÇÁ¸°ÆÃÀ¸·Î Á¦À۵ǾúÀ¸¸ç, 3D ÇÁ¸°ÆÃÀ» Ȱ¿ëÇϸé ÀÌ·¯ÇÑ ±¸¼º¿ä¼Ò¸¦ ½Å¼ÓÇÏ°Ô ÇÁ·ÎÅäŸÀÔÀ¸·Î Á¦ÀÛÇÏ¿© Áõ°¡ÇÏ´Â ¼ö¿ä¸¦ ÃæÁ·½Ãų ¼ö ÀÖ½À´Ï´Ù.

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀï ºÐ¼®

·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ºÐÀïÀÌ ÀÇ·á¿ë 3D ÇÁ¸°ÆÃ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº º¹ÀâÇÏ°í ´Ù¸éÀûÀÔ´Ï´Ù. Á¤ºÎ¿Í ÀÇ·á ½Ã½ºÅÛÀº ºÐÀïÀÌ ¹ß»ýÇÏ¸é ºñ»ó ´ëºñ, ÀÎÇÁ¶ó ¹× Çʼö ÀÇ·á ¿ä±¸ »çÇ×À» ¿ì¼±¼øÀ§¿¡ µÑ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á±â±â¿ë 3D ÇÁ¸°ÆÃ°ú °°Àº ÷´Ü ±â¼úÀÇ ¼ö¿ë°ú ÅõÀÚ´Â ÀÌ·¯ÇÑ ¿ì¼±¼øÀ§¿Í ÀÚ¿ø ¹èºÐÀÇ º¯È­·Î ÀÎÇØ ¿µÇâÀ» ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. º¸´Ù ±ä±ÞÇÏ°í ½Ã±ÞÇÑ ¼ö¿ä¿¡ ÀÚ±ÝÀÌ ÅõÀÔµÇ¾î ´õ ¸¹Àº °ü½ÉÀ» ²ø ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå Á¤ÀÇ¿Í °³¿ä

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå ¿ªÇÐ

  • ¿µÇâ¿äÀÎ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • Ä¡°ú ¾÷°èÀÇ ¼ö¿ä Áõ°¡
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
      • ÀÇ·á Á¦°øÀÚ¿¡ ÀÇÇÑ ÇÑÁ¤ÀûÀΠä¿ë
    • ±âȸ
      • ±â¼ú Áøº¸
    • ¿µÇ⠺м®

Á¦5Àå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ÌÃæÁ· ¼ö¿ä
  • ±ÔÁ¦ ºÐ¼®

Á¦6Àå COVID-19 ºÐ¼®

Á¦7Àå ·¯½Ã¾Æ¡¤¿ìÅ©¶óÀ̳ª ÀüÀï ºÐ¼®

Á¦8Àå ÀΰøÁö´É ºÐ¼®

Á¦9Àå Á¦Ç°º°

  • Àåºñ
    • 3D ÇÁ¸°ÅÍ
    • 3D ¹ÙÀÌ¿ÀÇÁ¸°ÅÍ
  • Àç·á
    • ÇÃ¶ó½ºÆ½
    • ±Ý¼Ó¡¤±Ý¼Ó ÇÕ±Ý
    • ¹ÙÀÌ¿À¼ÒÀç
    • ¼¼¶ó¹Í
    • ¿Î½º
    • ±âŸ
  • ¼­ºñ½º¡¤¼ÒÇÁÆ®¿þ¾î

Á¦10Àå ±â¼úº°

  • ·¹ÀÌÀú ºö ¿ëÇØ
  • ±¤ÁßÇÕ
  • ¾×Àû ÅðÀû/¾ÐÃâ ±â¹Ý ±â¼ú
  • ÀüÀÚºö ¿ëÇØ
  • 3Â÷¿ø ÇÁ¸°ÆÃ/Á¢Âø °áÇÕ/¹ÙÀδõ Á¦Æ®
  • ±âŸ ±â¼ú

Á¦11Àå ¿ëµµº°

  • ¼ö¼ú¿ë °¡À̵å
  • ¼ö¼ú±â±¸
  • Ç¥ÁØ º¸Ã¶¡¤ÀÓÇöõÆ®
  • Ä¿½ºÅÒ º¸Ã¶¡¤ÀÓÇöõÆ®
  • Á¶Á÷°øÇÐ Á¦Ç°
  • º¸Ã»±â
  • ¿þ¾î·¯ºí ÀÇ·á±â±â
  • ±âŸ ¿ëµµ

Á¦12Àå ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø¡¤¼ö¼ú ¼¾ÅÍ
  • Ä¡°ú¡¤Á¤Çü¿Ü°ú Ŭ¸®´Ð
  • Çмú±â°ü¡¤¿¬±¸¼Ò
  • Á¦¾à¡¤¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¡¤ÀÇ·á±â±â ±â¾÷
  • ÀÓ»ó ¿¬±¸±â°ü

Á¦13Àå Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ³²¹Ì
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • ±âŸ ³²¹Ì
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦14Àå °æÀï »óȲ

  • °æÀï ½Ã³ª¸®¿À
  • Á¦Ç° º¥Ä¡¸¶Å©
  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ÁÖ¿ä ¹ßÀü°ú Àü·«

Á¦15Àå ±â¾÷ °³¿ä

  • Stratasys Ltd.
    • ±â¾÷ °³¿ä
    • Á¦Ç° Æ÷Æ®Æú¸®¿À¿Í ¼³¸í
    • À繫 °³¿ä
    • ÁÖ¿ä ¹ßÀü
  • EnvisionTEC
  • Koninklijke Philips N.V.
  • 3D Systems, Inc.
  • EOS(US)
  • Renishaw plc
  • Materialise
  • 3T Additive Manufacturing Ltd.
  • General Electric Company
  • Carbon, Inc.
  • Prodways Group

Á¦16Àå ºÎ·Ï

ksm 23.08.04

Market Overview

The global medical device 3D printing market reached US$ 2.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 7.9 billion by 2030. The global medical device 3D printing market is expected to exhibit a CAGR of 15.7% during the forecast period (2023-2030).

The manufacturing of artificial limbs and orthotic devices has been transformed by 3D printing. The technique makes it possible to create lightweight, precisely fitting devices that are comfier and useful for the user.

Surgeons can use 3D printing to make surgical guidance and equipment that are unique to each patient. These manuals help to improve surgical outcomes, lower surgical risks, and aid in precise pre-operative preparation. Additionally, special tools might be created to meet certain surgical needs.

Market Dynamics

Active Key Players Are Boosting The Global Medical Device 3D Printing Market Growth During The Forecast Period

In June 2023, EOS, Precision ADM, Orthopaedic Innovation Centre (OIC), and Tecomet, four companies operating in the medical device manufacturing sector, established cooperation. An all-inclusive solution for the additive manufacture of medical devices will be offered by this cooperation.

Scaling up the manufacturing of AM medical devices necessitates a thorough understanding of the entire process chain, which goes beyond printing and includes, among other things, design, post-processing, testing, sterilization, and packaging. Incomparable experience in additive manufacturing will result from our collaboration with Tecomet, OIC, and Precision ADM, which will assist medical device manufacturers in navigating the difficulties of the regulatory environment and supplying high-quality, dependable goods.

Technological Advancements Provide The Global Medical Device 3D Printing Market Growth Opportunities

As per the article published in 3D Printing in Medicine, in 2022, through already-existing medical device rules, the Food & Drug Administration (FDA) of the United States controls 3D-printed devices. However, because 3D printing is spreading quickly throughout the healthcare industry, the FDA is becoming more and more interested in creating standards and regulations specifically for point-of-care (PoC) 3D printing.

Manufacturing of point-of-care (PoC) medical devices has rapidly increased as a result of recent developments in 3D-printed medical device research. Despite the fact that PoC 3D printing has the potential to enhance patient outcomes and cut down on operating room time and expenses, such a design and production environment blurs the distinction between medical device manufacturers and providers of treatment and raises regulatory uncertainty.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the medical device 3D printing market. The demand for testing kits and diagnostic tools surged as a result of the COVID-19 testing regulations. Nasopharyngeal swabs and sample-collecting containers were produced using 3D printing as part of testing kits and diagnostic tools. Utilizing 3D printing, it was possible to quickly prototype and produce these components, helping to satisfy the growing demand.

Russia-Ukraine Conflict Analysis

The impact of the Russia-Ukraine war on the medical device 3D printing market is complex and multifaceted. Governments and healthcare systems may prioritize emergency preparedness, infrastructure, and essential healthcare requirements during times of conflict. The acceptance and investment in cutting-edge technologies like 3D printing for medical devices could be impacted by this change in priorities and resource allocation. More urgent and immediate demands may receive funding and attention.

Segment Analysis

The global medical device 3D printing market is segmented based on product, technology, application, end-user, and region.

The Electron Beam Melting Segment Is Expected To Hold A Dominant Position In The Market Over The Forecast Period

The electron beam melting segment accounted for the highest market stake accounting for approximately 36.1% of the medical device 3D printing market in 2022. In the 3D manufacturing technique known as electron beam melting (EBM), a high-energy electron beam melts a metal powder. An object that precisely matches the criteria specified by a CAD model is created by melting multiple layers of powdered metal under the control of an electron beam, which generates an electron stream that is guided by a magnetic field.

In order to protect highly reactive materials from oxidation, production is done in a vacuum chamber. Similar to Selective Laser Melting (SLM), Electron Beam Melting (EBM) prints from a powder from the powder bed of the 3D printer, but EBM utilizes an electron beam as opposed to a laser.

Geographical Analysis

Increasing Collaborations and Partnerships Among the Key Players, Increasing FDA Approvals, and Advancement in Medical Device 3D Printing Dominate the North American Region

North America is expected to dominate the Medical Device 3D Printing market, accounting for around 38.7% of this market. In March 2023, with a collaboration with 3D Systems, the manufacturer of medical devices Paragon Medical is investing in additive manufacturing capabilities. According to reports, the new cooperation will make use of the historical knowledge and competencies that both institutions can offer to clients.

The collaboration between the companies covers material procurement and supply, part design and process development, machine onboarding and validation, and regulatory assistance. The partnership between 3D Systems and Paragon Medical will enable them to grow the production of medical devices using cutting-edge metal and plastic 3D printing technology.

Competitive Landscape

The major global players in the market include: Stratasys Ltd., EnvisionTEC, Koninklijke Philips N.V., 3D Systems, Inc., EOS, Renishaw plc, Materialise, 3T Additive Manufacturing Ltd., General Electric Company, Carbon, Inc., and Prodways Group among others.

Why Purchase the Report?

  • To visualize the global medical device 3D printing market segmentation based on the product, technology, application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of medical device 3D printing market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global medical device 3D printing market report would provide approximately 69 tables, 72 figures, and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Technology
  • 3.3. Snippet by Application
  • 3.4. Snippet by End-user
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing demand in the dental industry
    • 4.1.2. Restraints
      • 4.1.2.1. Limited adoption by healthcare providers
    • 4.1.3. Opportunity
      • 4.1.3.1. Technological advancements
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Unmet Needs
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19 Scenario
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. Artificial Intelligence Analysis

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. Equipment*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 9.2.3. 3D printers
    • 9.2.4. 3D Bioprinters
  • 9.3. Materials
    • 9.3.1. Plastics
    • 9.3.2. Metals and Metal Alloy
    • 9.3.3. Biomaterials
    • 9.3.4. Ceramics
    • 9.3.5. Wax
    • 9.3.6. Other
  • 9.4. Services and Software

10. By Technology

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 10.1.2. Market Attractiveness Index, By Technology
  • 10.2. Laser Beam Melting*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Photopolymerization
  • 10.4. Droplet Deposition/Extrusion-based Technologies
  • 10.5. Electron Beam Melting
  • 10.6. Three-dimensional Printing/Adhesion Bonding/Binder Jetting
  • 10.7. Other Technologies

11. By Application

    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.1.2. Market Attractiveness Index, By Application
  • 11.2. Surgical Guides*
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Surgical Instruments
  • 11.4. Standard Prosthetics and Implants
  • 11.5. Custom Prosthetics and Implants
  • 11.6. Tissue-Engineered Products
  • 11.7. Hearing Aids
  • 11.8. Wearable Medical Devices
  • 11.9. Other Applications

12. By End-user

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 12.1.2. Market Attractiveness Index, By End-user
  • 12.2. Hospitals and Surgical Centers*
    • 12.2.1. Introduction
    • 12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3. Dental and Orthopedic Clinics
  • 12.4. Academic Institutions and Research Laboratories
  • 12.5. Pharma-Biotech and Medical Device Companies
  • 12.6. Clinical Research Organizations

13. By Region

  • 13.1. Introduction
    • 13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2. Market Attractiveness Index, By Region
  • 13.2. North America
    • 13.2.1. Introduction
    • 13.2.2. Key Region-Specific Dynamics
    • 13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.7.1. U.S.
      • 13.2.7.2. Canada
      • 13.2.7.3. Mexico
  • 13.3. Europe
    • 13.3.1. Introduction
    • 13.3.2. Key Region-Specific Dynamics
    • 13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.7.1. Germany
      • 13.3.7.2. U.K.
      • 13.3.7.3. France
      • 13.3.7.4. Italy
      • 13.3.7.5. Spain
      • 13.3.7.6. Rest of Europe
  • 13.4. South America
    • 13.4.1. Introduction
    • 13.4.2. Key Region-Specific Dynamics
    • 13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.7.1. Brazil
      • 13.4.7.2. Argentina
      • 13.4.7.3. Rest of South America
  • 13.5. Asia-Pacific
    • 13.5.1. Introduction
    • 13.5.2. Key Region-Specific Dynamics
    • 13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
    • 13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.7.1. China
      • 13.5.7.2. India
      • 13.5.7.3. Japan
      • 13.5.7.4. Australia
      • 13.5.7.5. Rest of Asia-Pacific
  • 13.6. Middle East and Africa
    • 13.6.1. Introduction
    • 13.6.2. Key Region-Specific Dynamics
    • 13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user

14. Competitive Landscape

  • 14.1. Competitive Scenario
  • 14.2. Product Benchmarking
  • 14.3. Company Share Analysis
  • 14.4. Key Developments and Strategies

15. Company Profiles

  • 15.1. Stratasys Ltd.*
    • 15.1.1. Company Overview
    • 15.1.2. Product Portfolio and Description
    • 15.1.3. Financial Overview
    • 15.1.4. Key Developments
  • 15.2. EnvisionTEC
  • 15.3. Koninklijke Philips N.V.
  • 15.4. 3D Systems, Inc.
  • 15.5. EOS (US)
  • 15.6. Renishaw plc
  • 15.7. Materialise
  • 15.8. 3T Additive Manufacturing Ltd.
  • 15.9. General Electric Company
  • 15.10. Carbon, Inc.
  • 15.11. Prodways Group

LIST NOT EXHAUSTIVE

16. Appendix

  • 16.1. About Us and Services
  • 16.2. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦